Literature DB >> 26297098

Initial Medication Adherence-Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report.

David S Hutchins1, John E Zeber2, Craig S Roberts3, Allison F Williams4, Elizabeth Manias5, Andrew M Peterson6.   

Abstract

BACKGROUND: Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription.
OBJECTIVE: Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed.
METHODS: Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research.
RESULTS: The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber's and pharmacist's perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1-14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided.
CONCLUSIONS: General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  good research methodology; initial compliance; initial medication adherence; medication adherence

Mesh:

Year:  2015        PMID: 26297098     DOI: 10.1016/j.jval.2015.02.015

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  16 in total

1.  Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.

Authors:  Janice B Schwartz; Kenneth E Schmader; Joseph T Hanlon; Darrell R Abernethy; Shelly Gray; Jacqueline Dunbar-Jacob; Holly M Holmes; Michael D Murray; Robert Roberts; Michael Joyner; Josh Peterson; David Lindeman; Ming Tai-Seale; Laura Downey; Michael W Rich
Journal:  J Am Geriatr Soc       Date:  2018-12-07       Impact factor: 5.562

2.  Medication adherence: A practical measurement selection guide using case studies.

Authors:  Leah L Zullig; Phil Mendys; Hayden B Bosworth
Journal:  Patient Educ Couns       Date:  2017-02-10

Review 3.  Advancing the Science and Practice of Medication Adherence.

Authors:  Michael J Stirratt; Jeffrey R Curtis; Maria I Danila; Richard Hansen; Michael J Miller; C Ann Gakumo
Journal:  J Gen Intern Med       Date:  2018-02       Impact factor: 5.128

4.  Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients.

Authors:  Ignacio Aznar-Lou; Ana Fernández; Montserrat Gil-Girbau; Marta Fajó-Pascual; Patricia Moreno-Peral; María Teresa Peñarrubia-María; Antoni Serrano-Blanco; Albert Sánchez-Niubó; María Antonia March-Pujol; Anna Maria Jové; Maria Rubio-Valera
Journal:  Br J Clin Pharmacol       Date:  2017-02-24       Impact factor: 4.335

5.  What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?-a protocol for a systematic review.

Authors:  Victoria Memoli; Giraud Ekanmian; Sophie Lauzier; Line Guénette; Carlotta Lunghi; Anne-Déborah Bouhnik
Journal:  Syst Rev       Date:  2022-05-23

6.  Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study).

Authors:  Alba Sánchez-Viñas; Carmen Corral-Partearroyo; Montserrat Gil-Girbau; M Teresa Peñarrubia-María; Carmen Gallardo-González; María-Del-Carmen Olmos-Palenzuela; Ignacio Aznar-Lou; Antoni Serrano-Blanco; Maria Rubio-Valera
Journal:  BMC Prim Care       Date:  2022-07-05

7.  Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain.

Authors:  Ignacio Aznar-Lou; Ana Fernández; Montserrat Gil-Girbau; Ramón Sabés-Figuera; Marta Fajó-Pascual; María Teresa Peñarrubia-María; Antoni Serrano-Blanco; Patricia Moreno-Peral; Albert Sánchez-Niubó; Marian March-Pujol; Maria Rubio-Valera
Journal:  Br J Gen Pract       Date:  2017-07-31       Impact factor: 5.386

8.  Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.

Authors:  Eric D Shah; Suraj Suresh; Jessica Jou; William D Chey; Ryan W Stidham
Journal:  Am J Gastroenterol       Date:  2020-04       Impact factor: 12.045

9.  Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors.

Authors:  Sue P Heiney; Samantha Truman; Oluwole A Babatunde; Tisha M Felder; Jan M Eberth; Elizabeth Crouch; Karen E Wickersham; Swann Arp Adams
Journal:  Am J Clin Oncol       Date:  2020-07       Impact factor: 2.787

10.  Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance.

Authors:  Enrica Menditto; Caitriona Cahir; Sara Malo; Isabel Aguilar-Palacio; Marta Almada; Elisio Costa; Anna Giardini; María Gil Peinado; Mireia Massot Mesquida; Sara Mucherino; Valentina Orlando; Carlos Luis Parra-Calderón; Enrique Pepiol Salom; Przemyslaw Kardas; Bernard Vrijens
Journal:  Int J Environ Res Public Health       Date:  2021-05-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.